Market Overview

The Probiotic IBS Supplements Market reached US$29.12 million in 2023 and is expected to reach US$48.79 million by 2031, growing at a CAGR of 7.65% during the forecast period 2024-2031. The Probiotic IBS Supplements Market is flourishing as consumers seek natural remedies for digestive woes. IBS affects 5-10% globally, spurring demand for microbiota-balancing products. Research validates probiotics' role in symptom relief, like reduced bloating.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/probiotic-ibs-supplements-market

Market Drivers:

Rising IBS prevalence. Affecting 25-45 million in the U.S. alone, it drives visits for gut-focused solutions.

Consumer preference for natural remedies. 51% of Americans use probiotics for digestive health, favoring holistic approaches.

Research-backed efficacy. Studies show strains reduce inflammation and improve barrier function.

Wellness trend integration. Daily inclusion in diets, with 33% for immune support, broadens appeal.

Market Restraints:

Competition from pharmaceuticals. Quick-relief drugs like antispasmodics overshadow supplements.

Limited clinical standardization. Variability in strains questions consistent outcomes.

Shelf-life and formulation challenges. Maintaining viability in products affects quality.

Awareness gaps in emerging markets. Lower education limits adoption.

Market Geographical Share:

North America dominates, with high IBS rates and wellness culture. U.S. consumers lead probiotic intake.

Europe follows, supported by research and regulatory trust in supplements.

Asia-Pacific grows steadily, with India and China embracing gut health amid urbanization.

South America and Middle East & Africa emerge, with Brazil focusing on accessible formats.

Market Segments:

By Strain

• Lactobacillus
• Bifidobacterium
• Others

By Form

• Tablet
• Capsules

By Distribution Channel

• Supermarkets/Hypermarkets
• Pharmacy/Health Stores

By End-User

• Adults
• Seniors

Market Key Players:

Key players are The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited, Unique Biotech Limited, Projoy Pvt Ltd, Pure NSM - Nutritional Supplement Manufacturers, Inc., Nature's Bounty, Hyperbiotics, Advanced Vital Enzymes Private Ltd, Wren Laboratories Ltd.

Latest Developments:

Hyperbiotics launched PRO-IBS Support in August 2023, blending Lactiplantibacillus plantarum with Boswellia for discomfort relief.

University of Nottingham secured £1.8 million in August 2022 for cellulose supplements research targeting IBS fermentation.

Ongoing trials explore Bifidobacterium bifidum MIMBb75 for symptom management in various forms.

Industry shifts toward heat-stable strains enhance product stability.

Collaborations advance strain-specific formulations for personalized care

About DataM Intelligence 4Market Research:

DataM Intelligence 4Market Research is a market intelligence platform that gives access to syndicated, customized reports and consulting to its clients in one place. As a firm with rich experience in research and consulting across multiple domains, we are a one-stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed, and food & beverages among others. Our platform has Insights on markets that uncover the latest market research data that are distinct from the competition. With coverage across 10 major industries in the marketplace research, DataM Intelligence benefits thousands of companies by helping them take their innovations early to the market, by providing a complete view of the market with statistical forecasts. Our strategy-centric framework and value-added services will let individuals and corporates with ease of access and custom personalization to research and markets.

Key Highlights of Report:

Market Growth: The Probiotic IBS Supplements Market is projected to grow at a CAGR of 7.65% during 2024-2031.

Bifidobacterium Lead: Strains like infantis dominate for proven IBS benefits.

North America Strength: High prevalence secures regional dominance.

Natural Remedy Trend: Consumer shifts favor probiotics over synthetics.

Research Momentum: Meta-analyses validate gut health impacts.

Conclusion:

The Probiotic IBS Supplements Market signals a shift toward proactive digestive wellness, leveraging science for everyday relief.